نتایج جستجو برای: s boulardii

تعداد نتایج: 711322  

2015
Juliana Fonseca Moreira da Silva Joenes Mucci Peluzio Guilherme Prado Jovita Eugênia Gazzinelli Cruz Madeira Marize Oliveira Silva Paula Benevides de Morais Carlos Augusto Rosa Raphael Sanzio Pimenta Jacques Robert Nicoli

Probiotic microorganisms (Saccharomyces cerevisiae var. boulardii, S. cerevisiae UFMG 905, and Lactobacillus delbrueckii UFV H2b20) were evaluated as biological control agents to reduce aflatoxin and spore production by Aspergillus parasiticus IMI 242695 in peanut. Suspensions containing the probiotics alone or in combinations were tested by sprinkling on the grains followed by incubation for s...

2017
Serkan Atıcı Ahmet Soysal Kıvılcım Karadeniz Cerit Şerife Yılmaz Burak Aksu Gürsu Kıyan Mustafa Bakır

Although Saccharomyces boulardii is usually a non-pathogenic fungus, in rare occasions it can cause invasive infection in children. We present the case of an 8-year-old patient in pediatric surgical intensive care unit who developed S. cerevisiae fungemia following probiotic treatment containing S. boulardii. Caspofungin was not effective in this case and he was treated with amphotericin B. We ...

Journal: :Journal of the science of food and agriculture 2017
Suprama Datta David J Timson Uday S Annapure

BACKGROUND Saccharomyces cerevisiae var. boulardii is the only yeast species with probiotic properties. It is considered to have therapeutic significance in gastrointestinal disorders. In the present study, a comparative physiological study between this yeast and Saccharomyces cerevisiae (BY4742) was performed by evaluating two prominent traits of probiotic species, responses to different stres...

2013
Indu Khatri Akil Akhtar Kamaldeep Kaur Rajul Tomar Gandham Satyanarayana Prasad Thirumalai Nallan Chakravarthy Ramya Srikrishna Subramanian

BACKGROUND The yeast Saccharomyces boulardii is used worldwide as a probiotic to alleviate the effects of several gastrointestinal diseases and control antibiotics-associated diarrhea. While many studies report the probiotic effects of S. boulardii, no genome information for this yeast is currently available in the public domain. RESULTS We report the 11.4 Mbp draft genome of this probiotic y...

Journal: :medical journal of islamic republic of iran 0
k yazdanparast from tile dept. of microbiology and the dept. of medicine, shiraz university of medical sciences,shiraz, islamic republic of lran n dehbashi f mansour ghanaie

intestinal amebiasis has a worldwide distribution and is common in tropical and subtropical areas. [n this prospective 7-month study, we studied the main clinical findings in patients with acute amebic proctocolitis and the efficacy of saccharomyces boulardii (sb) treatment of these patients.initially, 57 cases with acute amebic proctocolitis were selected. the maximum occurrence of infection w...

2016
Stephan Ehrhardt Nan Guo Rebecca Hinz Stefanie Schoppen Jürgen May Markus Reiser Maximilian Philipp Schroeder Stefan Schmiedel Martin Keuchel Emil C. Reisinger Andreas Langeheinecke Andreas de Weerth Marcus Schuchmann Tom Schaberg Sandra Ligges Maria Eveslage Ralf M. Hagen Gerd D. Burchard Ansgar W. Lohse Bernhard Ruf Rainer Porschen Guido Trenn Trude Butterfaß-Bahloul Gudrun Wuerthwein Frank Oeder Andreas Runge Esther Klauss Nina Hansen-Rosenblatt Tobias Werner Kornelius Schulze Benno Kreuels Guido Schäfer Peter Hübener Annette Hennigs Claudia Beisel Dorothee Fischer-Brügge Katharina Zimmermann-Fraedrich Claudia Röder Nadine Grigo Armin Riecke Helmut Schreckenbauer Christoph Hemmer Sebastian Klammt Hilte Geerdes-Fenge Silvius Frimmel Jens M. Kittner Johannes W. Rey Joern M. Schattenberg Florian Thieringer Rudolf Schmits Daniel Grandt Philipp Martin Büch Alexander Klebert Marc Andreas Mittag Sybille Lehnen Daniel Tiefengraber Klaus Radecke Iris Hering Wolfgang Zeller Lisa Rundt Lars Brandt Peter Baltes Dani Dajani Niehls Kurniawan Carola Pflüger Nassim Behjat Ulrike Engel Martina Unger

Background.  Antibiotic-associated diarrhea (AAD) and Clostridium difficile-associated diarrhea (CDAD) are common complications of antibiotic use. Data on the efficacy of probiotics to prevent AAD and CDAD are unclear. We aimed to evaluate the efficacy of Saccharomyces boulardii to prevent AAD and CDAD in hospitalized adult patients. Methods.  We conducted a multicenter, phase III, double-maske...

2011
Elizabeth P. Ryan Adam L. Heuberger Tiffany L. Weir Brittany Barnett Corey D. Broeckling Jessica E. Prenni

Emerging evidence supporting chronic disease fighting properties of rice bran has advanced the development of stabilized rice bran for human use as a functional food and dietary supplement. A global and targeted metabolomic investigation of stabilized rice bran fermented with Saccharomyces boulardii was performed in three rice varieties. Metabolites from S. boulardii-fermented rice bran were de...

Journal: :Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2000
C M Surawicz L V McFarland R N Greenberg M Rubin R Fekety M E Mulligan R J Garcia S Brandmarker K Bowen D Borjal G W Elmer

Recurrent Clostridium difficile disease (CDD) is a difficult clinical problem because antibiotic therapy often does not prevent further recurrences. In a previous study, the biotherapeutic agent Saccharomyces boulardii was used in combination with standard antibiotics and was found to be effective in reducing subsequent recurrences of CDD. In an effort to further refine a standard regimen, we t...

Journal: :European journal of gastroenterology & hepatology 2003
Mario Guslandi Patrizia Giollo Pier Alberto Testoni

OBJECTIVES Probiotics can be useful in the treatment of inflammatory bowel disease. In a previous report, the non-pathogenic yeast Saccharomyces boulardii was found to be beneficial in the maintenance treatment of Crohn's disease. The aim of this study was to assess the efficacy of S. boulardii in ulcerative colitis patients. METHODS A group of 25 patients with a mild to moderate clinical fla...

2012
Yvan Vandenplas

Objective: To evaluate Saccharomyces boulardii in the management of gastroenteritis in children in Togo, Benin and Côte d’Ivoire. Methods: Prospective descriptive study, conducted by healthcare personnel in the 3 West African countries between May and December 2006. Well-nourished, (1 month -15 years old) children without chronic disease presenting with acute diarrhea (defined as more than 3 lo...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید